Phospho-PKC zeta (Thr410) Antibody - #AF3404
製品説明
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
引用形式: Affinity Biosciences Cat# AF3404, RRID:AB_2834787.
折りたたみ/展開
14-3-3-zetaisoform; AI098070; aPKCzeta; C80388; EC 2.7.11.13; KPCZ_HUMAN; nPKC zeta; nPKC-zeta; OTTHUMP00000001368; OTTHUMP00000044160; PKC 2; PKC ZETA; PKC2; Pkcz; PKCZETA; PKM-zeta, included; PRKCZ; Protein kinase C zeta; Protein kinase C zeta form; Protein kinase C zeta type; r14-3-3; R74924; zetaPKC;
免疫原
- Q05513 KPCZ_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MPSRTGPKMEGSGGRVRLKAHYGGDIFITSVDAATTFEELCEEVRDMCRLHQQHPLTLKWVDSEGDPCTVSSQMELEEAFRLARQCRDEGLIIHVFPSTPEQPGLPCPGEDKSIYRRGARRWRKLYRANGHLFQAKRFNRRAYCGQCSERIWGLARQGYRCINCKLLVHKRCHGLVPLTCRKHMDSVMPSQEPPVDDKNEDADLPSEETDGIAYISSSRKHDSIKDDSEDLKPVIDGMDGIKISQGLGLQDFDLIRVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEKKQALPPFQPQITDDYGLDNFDTQFTSEPVQLTPDDEDAIKRIDQSEFEGFEYINPLLLSTEESV
種類予測
Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.
High(score>80) Medium(80>score>50) Low(score<50) No confidence
PTMs - Q05513 基板として
Site | PTM Type | Enzyme | Source |
---|---|---|---|
S148 | Phosphorylation | Uniprot | |
S190 | Phosphorylation | Uniprot | |
S206 | Phosphorylation | Uniprot | |
S223 | Phosphorylation | Uniprot | |
S228 | Phosphorylation | Uniprot | |
T407 | Phosphorylation | Uniprot | |
S409 | Phosphorylation | Uniprot | |
T410 | Phosphorylation | O15530 (PDPK1) | Uniprot |
Y417 | Phosphorylation | Uniprot | |
Y428 | Phosphorylation | Uniprot | |
T560 | Phosphorylation | Q05513 (PRKCZ) | Uniprot |
PTMs - Q05513 酵素として
Substrate | Site | Source |
---|---|---|
O14920 (IKBKB) | S177 | Uniprot |
O14920 (IKBKB) | S181 | Uniprot |
O14965 (AURKA) | T287 | Uniprot |
O43175 (PHGDH) | S55 | Uniprot |
O43175 (PHGDH) | T57 | Uniprot |
O43175 (PHGDH) | T78 | Uniprot |
O43315 (AQP9) | S11 | Uniprot |
O43315 (AQP9) | S222 | Uniprot |
P05023 (ATP1A1) | S16 | Uniprot |
P08047 (SP1) | S641 | Uniprot |
P08047 (SP1) | T668 | Uniprot |
P08047 (SP1) | S670 | Uniprot |
P08047 (SP1) | T681 | Uniprot |
P10636-8 (MAPT) | S258 | Uniprot |
P10636-8 (MAPT) | S293 | Uniprot |
P10636-8 (MAPT) | S324 | Uniprot |
P10636-8 (MAPT) | S352 | Uniprot |
P14598 (NCF1) | S303 | Uniprot |
P14598 (NCF1) | S304 | Uniprot |
P14598 (NCF1) | S315 | Uniprot |
P14598 (NCF1) | S320 | Uniprot |
P14598 (NCF1) | S328 | Uniprot |
P14598 (NCF1) | S359 | Uniprot |
P14598 (NCF1) | S370 | Uniprot |
P14598 (NCF1) | S379 | Uniprot |
P17252 (PRKCA) | S657 | Uniprot |
P27448 (MARK3) | T564 | Uniprot |
P28329-3 (CHAT) | S440 | Uniprot |
P28329-3 (CHAT) | S476 | Uniprot |
P28329 (CHAT) | S558 | Uniprot |
P28329 (CHAT) | S594 | Uniprot |
P29474 (NOS3) | T495 | Uniprot |
P30086 (PEBP1) | S153 | Uniprot |
P31749 (AKT1) | T34 | Uniprot |
P31946-1 (YWHAB) | S132 | Uniprot |
P31946-1 (YWHAB) | T143 | Uniprot |
P35222 (CTNNB1) | S45 | Uniprot |
P35568 (IRS1) | S323 | Uniprot |
P35568 (IRS1) | S441 | Uniprot |
P35568 (IRS1) | S1101 | Uniprot |
P35580 (MYH10) | S1937 | Uniprot |
P35611 (ADD1) | S726 | Uniprot |
P35612 (ADD2) | S713 | Uniprot |
P41594-2 (GRM5) | S840 | Uniprot |
P46937 (YAP1) | S109 | Uniprot |
P46937 (YAP1) | T110 | Uniprot |
P49757-2 (NUMB) | S7 | Uniprot |
P49757-2 (NUMB) | S295 | Uniprot |
P49768 (PSEN1) | S346 | Uniprot |
P49841 (GSK3B) | S9 | Uniprot |
P49841 (GSK3B) | S147 | Uniprot |
P55040 (GEM) | S261 | Uniprot |
P55211 (CASP9) | S144 | Uniprot |
P60484 (PTEN) | S380 | Uniprot |
P60484 (PTEN) | T382 | Uniprot |
P60484 (PTEN) | T383 | Uniprot |
P61587 (RND3) | S210 | Uniprot |
Q04206 (RELA) | S311 | Uniprot |
Q05513-2 (PRKCZ) | T377 | Uniprot |
Q05513 (PRKCZ) | T560 | Uniprot |
Q05655-1 (PRKCD) | S664 | Uniprot |
Q07812 (BAX) | S184 | Uniprot |
Q12933 (TRAF2) | S55 | Uniprot |
Q13164 (MAPK7) | S486 | Uniprot |
Q13469 (NFATC2) | S53 | Uniprot |
Q13469 (NFATC2) | S56 | Uniprot |
Q15139 (PRKD1) | S738 | Uniprot |
Q15139 (PRKD1) | S742 | Uniprot |
Q15466 (NR0B2) | T55 | Uniprot |
Q15831 (STK11) | S307 | Uniprot |
Q15831-2 (STK11) | S399 | Uniprot |
Q15831 (STK11) | S428 | Uniprot |
Q16612 (NREP) | S59 | Uniprot |
Q16625 (OCLN) | T403 | Uniprot |
Q16625 (OCLN) | T404 | Uniprot |
Q16625 (OCLN) | T424 | Uniprot |
Q16625 (OCLN) | T438 | Uniprot |
Q5JVS0-1 (HABP4) | T354 | Uniprot |
Q5JVS0 (HABP4) | T375 | Uniprot |
Q6STE5 (SMARCD3) | S247 | Uniprot |
Q7KZI7 (MARK2) | T596 | Uniprot |
Q8IX03-1 (WWC1) | S975 | Uniprot |
Q8IX03-1 (WWC1) | S978 | Uniprot |
Q8TEW0 (PARD3) | S827 | Uniprot |
Q96A00-1 (PPP1R14A) | T38 | Uniprot |
Q96RI1-2 (NR1H4) | T442 | Uniprot |
Q96RI1 (NR1H4) | T456 | Uniprot |
Q9UBS0 (RPS6KB2) | S473 | Uniprot |
Q9Y243 (AKT3) | T305 | Uniprot |
Q9Y243 (AKT3) | S472 | Uniprot |
Q9Y6Q9 (NCOA3) | S1033 | Uniprot |
Q9Y6Q9 (NCOA3) | S1042 | Uniprot |
Q9Y6Q9 (NCOA3) | S1048 | Uniprot |
Q9Y6Q9 (NCOA3) | T1059 | Uniprot |
Q9Y6Q9 (NCOA3) | S1062 | Uniprot |
Q9Y6Q9 (NCOA3) | T1064 | Uniprot |
Q9Y6Q9 (NCOA3) | T1067 | Uniprot |
Q9Y6Q9 (NCOA3) | T1114 | Uniprot |
研究背景
Calcium- and diacylglycerol-independent serine/threonine-protein kinase that functions in phosphatidylinositol 3-kinase (PI3K) pathway and mitogen-activated protein (MAP) kinase cascade, and is involved in NF-kappa-B activation, mitogenic signaling, cell proliferation, cell polarity, inflammatory response and maintenance of long-term potentiation (LTP). Upon lipopolysaccharide (LPS) treatment in macrophages, or following mitogenic stimuli, functions downstream of PI3K to activate MAP2K1/MEK1-MAPK1/ERK2 signaling cascade independently of RAF1 activation. Required for insulin-dependent activation of AKT3, but may function as an adapter rather than a direct activator. Upon insulin treatment may act as a downstream effector of PI3K and contribute to the activation of translocation of the glucose transporter SLC2A4/GLUT4 and subsequent glucose transport in adipocytes. In EGF-induced cells, binds and activates MAP2K5/MEK5-MAPK7/ERK5 independently of its kinase activity and can activate JUN promoter through MEF2C. Through binding with SQSTM1/p62, functions in interleukin-1 signaling and activation of NF-kappa-B with the specific adapters RIPK1 and TRAF6. Participates in TNF-dependent transactivation of NF-kappa-B by phosphorylating and activating IKBKB kinase, which in turn leads to the degradation of NF-kappa-B inhibitors. In migrating astrocytes, forms a cytoplasmic complex with PARD6A and is recruited by CDC42 to function in the establishment of cell polarity along with the microtubule motor and dynein. In association with FEZ1, stimulates neuronal differentiation in PC12 cells. In the inflammatory response, is required for the T-helper 2 (Th2) differentiation process, including interleukin production, efficient activation of JAK1 and the subsequent phosphorylation and nuclear translocation of STAT6. May be involved in development of allergic airway inflammation (asthma), a process dependent on Th2 immune response. In the NF-kappa-B-mediated inflammatory response, can relieve SETD6-dependent repression of NF-kappa-B target genes by phosphorylating the RELA subunit at 'Ser-311'. In vein endothelial cells treated with the oxidant peroxynitrite, phosphorylates STK11 leading to nuclear export of STK11, subsequent inhibition of PI3K/Akt signaling, and increased apoptosis. Phosphorylates VAMP2 in vitro.
Involved in late synaptic long term potention phase in CA1 hippocampal cells and long term memory maintenance.
CDH5 is required for its phosphorylation at Thr-410. Phosphorylated by protein kinase PDPK1; phosphorylation is inhibited by the apoptotic C-terminal cleavage product of PKN2. Phosphorylation at Thr-410 by PI3K activates the kinase.
Cytoplasm. Endosome. Cell junction. Membrane>Peripheral membrane protein.
Note: In the retina, localizes in the terminals of the rod bipolar cells (By similarity). Associates with endosomes (PubMed:9566925). Presence of KRIT1, CDH5 and RAP1B is required for its localization to the cell junction (PubMed:7597083). Colocalizes with VAMP2 and WDFY2 in intracellular vesicles (PubMed:17313651). Transiently translocates to the membrane of CA1 hippocampal cells in response to the induction of long term potentiation (By similarity).
Cytoplasm.
Expressed in brain, and to a lesser extent in lung, kidney and testis.
Forms a ternary complex with SQSTM1 and KCNAB2. Forms another ternary complex with SQSTM1 and GABRR3. Forms a complex with SQSTM1 and MAP2K5 (By similarity). Interacts with PARD6A, PARD6B, PARD6G and SQSTM1. Part of a complex with PARD3, PARD6A or PARD6B or PARD6G and CDC42 or RAC1. Interacts with ADAP1/CENTA1. Forms a ternary complex composed of SQSTM1 and PAWR. Interacts directly with SQSTM1 (Probable). Interacts with IKBKB. Interacts (via the protein kinase domain) with WWC1. Forms a tripartite complex with WWC1 and DDR1, but predominantly in the absence of collagen. Component of the Par polarity complex, composed of at least phosphorylated PRKCZ, PARD3 and TIAM1. Interacts with PDPK1 (via N-terminal region). Interacts with WDFY2 (via WD repeats 1-3). Interacts with VAMP2. Forms a complex with WDFY2 and VAMP2. Interacts with APPL1.
The PB1 domain mediate mutually exclusive interactions with SQSTM1 and PARD6B.
The C1 domain does not bind the diacylglycerol (DAG).
Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. PKC subfamily.
研究領域
· Cellular Processes > Transport and catabolism > Endocytosis. (View pathway)
· Cellular Processes > Cellular community - eukaryotes > Tight junction. (View pathway)
· Environmental Information Processing > Signal transduction > Rap1 signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > Sphingolipid signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > Hippo signaling pathway. (View pathway)
· Human Diseases > Endocrine and metabolic diseases > Type II diabetes mellitus.
· Human Diseases > Endocrine and metabolic diseases > Insulin resistance.
· Human Diseases > Infectious diseases: Viral > Human papillomavirus infection.
· Organismal Systems > Immune system > Chemokine signaling pathway. (View pathway)
· Organismal Systems > Development > Axon guidance. (View pathway)
· Organismal Systems > Immune system > Platelet activation. (View pathway)
· Organismal Systems > Endocrine system > Insulin signaling pathway. (View pathway)
· Organismal Systems > Endocrine system > Relaxin signaling pathway.
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.